selegiline has been researched along with Erectile Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berner, MM; Hagen, M; Kriston, L; Maayan, N; Schmidt, HM; Soares-Weiser, K | 1 |
| Berner, MM; Hagen, M; Kriston, L | 2 |
| Chouinard, S; Fahn, S | 1 |
3 review(s) available for selegiline and Erectile Dysfunction
| Article | Year |
|---|---|
Management of sexual dysfunction due to antipsychotic drug therapy.
Topics: Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Drug Substitution; Erectile Dysfunction; Female; Humans; Male; Olanzapine; Piperazines; Purines; Randomized Controlled Trials as Topic; Selegiline; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2012 |
A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.
Topics: Antipsychotic Agents; Erectile Dysfunction; Female; Humans; Male; Monoamine Oxidase Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Research; Research Design; Schizophrenia; Selegiline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Treatment Outcome | 2006 |
Management of sexual dysfunction due to antipsychotic drug therapy.
Topics: Antipsychotic Agents; Cross-Over Studies; Erectile Dysfunction; Female; Humans; Male; Piperazines; Purines; Randomized Controlled Trials as Topic; Selegiline; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2007 |
1 trial(s) available for selegiline and Erectile Dysfunction
| Article | Year |
|---|---|
Experience with tranylcypromine in early Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Erectile Dysfunction; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders; Time Factors; Tranylcypromine; Tyramine | 1998 |